Melanoma Cells that Secrete Interleukin-2 (IL-2) in Patients with Metastatic 
Melanoma and (2) Immunization with IL-2 Secreting Allogeneic HLA-A2 Matched Renal 
Renal Cell Carcinoma Cells in Patients with Advanced Renal Cell Carcinoma 
/Dr. Gansbacher 38 
XI. Proposed Addition to Appendix D of the NIH Guidelines Regarding Human Gene 
Transfer Protocols Entitled: (1) Genetic Marking with Retroviral Vectors 
to Study the Biology of Hematopoietic Reconstitution After Autologous 
Transplantation for Multiple Myeloma, (2) Retroviral Vectors to Study the Biology 
of Hematopoietic Reconstitution After Autologous Transplantation for Breast 
Cancer, and (3) Genetic Marking with Retroviral Vectors to Study the Biology of 
Hematopoietic Reconstitution After Autologous Transplantation for Chronic Myelogenous 
Leukemia /Dr. Dunbar 46 
XII. Proposed Addition to the Points to Consider in the Design and Submission of Protocols 
for the Transfer of Recombinant DNA into the Genome of Human Subjects Regarding 
Submission Requirements for Human Gene Transfer/Therapy Protocols 59 
XIII. Proposed Addition to Section IV-C-2 of the NIH Guidelines Regarding Conflicts 
of Interest 62 
XIV. Future Meeting Date of the Recombinant DNA Advisory Committee 64 
XV. Adjournment 64 
Attachment - Roster 
[ 666 ] 
Recombinant DNA Research, Volume 15 
